These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15073835)

  • 1. Spontaneous reports of drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Denmark 1968-1991.
    Gaist D; Andersen M; Schou JS
    Pharmacoepidemiol Drug Saf; 1996 Mar; 5(2):79-86. PubMed ID: 15073835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL; Stern RS; Arndt KA; Langlois J; Jick SS; Jick H; Walker AM
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Rzany B; Hering O; Mockenhaupt M; Schröder W; Goerttler E; Ring J; Schöpf E
    Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylaxis and toxic epidermal necrolysis or Stevens-Johnson syndrome after nonmucosal topical drug application: fact or fiction?
    Sachs B; Fischer-Barth W; Erdmann S; Merk HF; Seebeck J
    Allergy; 2007 Aug; 62(8):877-83. PubMed ID: 17620064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
    Sane SP; Bhatt AD
    J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous adverse event reports of Stevens-Johnson syndrome/toxic epidermal necrolysis: detecting associations with medications.
    Papay J; Yuen N; Powell G; Mockenhaupt M; Bogenrieder T
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):289-96. PubMed ID: 22139991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
    Assier H; Bastuji-Garin S; Revuz J; Roujeau JC
    Arch Dermatol; 1995 May; 131(5):539-43. PubMed ID: 7741539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythema multiforme. A heterogeneous pathologic phenotype].
    Carrozzo M; Togliatto M; Gandolfo S
    Minerva Stomatol; 1999 May; 48(5):217-26. PubMed ID: 10434539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
    Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience.
    Forman R; Koren G; Shear NH
    Drug Saf; 2002; 25(13):965-72. PubMed ID: 12381216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
    Yager JA
    Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.